Articles  |   September 2015
SEE Question
Article Information
Cardiovascular Anesthesia / Articles
Articles   |   September 2015
SEE Question
ASA Monitor 09 2015, Vol.79, 60-61.
ASA Monitor 09 2015, Vol.79, 60-61.
Authors of a recent randomized study sought to determine the relative risks and benefits of continuing dual antiplatelet therapy (DAPT) beyond one year after coronary drug-eluting stent (DES) placement. According to the study, which of the following statements is most likely true regarding patients whose DAPT was continued beyond one year?
DAPT is recommended after implantation of cardiac DES to prevent in-stent thrombosis. Current guidelines from the American Heart Association/American College of Cardiology and European Society of Cardiology recommend continuation of DAPT for at least 12 months in the absence of major bleeding complications. Whether continuing DAPT beyond 12 months is beneficial remains controversial.
Submit a Comment
Submit A Comment

Contributors must reveal any conflict of interest. Comments are moderated.

Affiliation & Institution
I have a potential conflict of interest
Comment Title

This feature is available to Subscribers Only
ASA Member Login or Create an Account ×